Local and distant histopathological effects of unilateral amyloid-β 25-35 injections into the amygdala of young F344 rats

Neurobiology of Aging

Volumn 17, Issue 6, 1996, Pages 893-901

  Sigurdsson, Einar M ^a   Lorens, Stanley A ^a   Hejna, Matthew J ^a   Dong, Xin W ^a   Lee, John M ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alz 50; Alzheimer's disease; amygdala; amyloid protein; animal model; GFAP; hippocampus; rat; reactive astrocytosis; tau protein; tau 2; transsynaptic effects

Indexed keywords

AMYLOID BETA PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; AMYLOID NEUROPATHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

AMYGDALA; AMYLOID BETA-PROTEIN; ANIMALS; ANTIGENS; BRAIN; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; MALE; MICROINJECTIONS; NEUROTOXINS; OXAZINES; PEPTIDE FRAGMENTS; RATS; RATS, INBRED F344; TAU PROTEINS;

EID: 0030292993     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(96)00169-8     Document Type: Article

References (75)

1. 1. Arispe, N.; Rojas, E.; Pollard, H.B. Alzheimer disease amyloid β protein forms calcium channels in bilayer membranes: Blockade by tromethamine and aluminum. Proc. Natl. Acad. Sci. USA 90:567-571; 1993.
2. 2. Binder, L. I.; Frankfurter, A.; Rebhun, L. I. The distribution of tau in the mammalian central nervous system. J. Cell Biol. 101:1371-1378; 1985.
3. 3. Buee, L.; Laine, A.; Delacourte, A.; Flament, S.; Han, K.-K. Qualitative and quantitative comparison of brain proteins in Alzheimer's disease. Biol. Chem. Hoppe-Seyler 370:1229-1234; 1989.
4. 4. Burger, P. C.; Vogel, F. S. The development of the pathological changes of Alzheimer's disease and senile dementia in patients with Down's syndrome. Am. J. Pathol. 73:457-476; 1973.
5. 5. Busciglio, J.; Lorenzo, A.; Yankner, B. Methodological variables in the assessment of beta amyloid neurotoxicity. Neurobiol. Aging 13: 609-612; 1992.
6. 6. Busciglio, J.; Lorenzo, A.; Yeh, J.; Yankner, B. A. β-Amyloid induces tau phosphorylation and loss of microtubule binding. Neuron 14:879-888; 1995.
7. 7. Byne, W.; Mattiace, L.; Kress, Y.; Davies, P. Alz-50 immunoreactivity in the hypothalamus of the normal and Alzheimer human and the rat. J. Comp. Neurol. 306:602-619; 1991.
8. 8. Clemens, J. A.; Stephenson, D. T. Implants containing β-amyloid protein are not neurotoxic to young and old rat brain. Neurobiol. Aging 13:581-586; 1992.
9. 9. Davies, P. Alz-50 as a reagent to assess animal models of Alzheimer's disease. Neurobiol. Aging 13:613-614; 1992.
10. 10. Delacourte, A. General and dramatic glial reaction in Alzheimer brains. Neurology 40:33-37; 1990.
11. 11. Duffy, P. E.; Rapport, M.; Graf, L. Glial fibrillary acid protein and Alzheimer-like dementia. Neurology 30:778-782; 1980.
12. 12. Frautschy, S. A.; Baird, A.; Cole, G. M. Effects of injected Alzheimer β-amyloid cores in rat brain. Proc. Natl. Acad. Sci. USA 88:8362-8366; 1991.
13. 13. Games, D.; Khan, K. M.; Soriano, F. G.; Keim, P. S.; Davis, D. L.; Bryant, K.; Lieberburg, I. Lack of Alzheimer pathology after β-amyloid protein injections in rat brain. Neurobiol. Aging 13:569-576; 1992.
14. 14. Games, D.; Adams, D.; Alessandrini, R.; Barbour, R.; Berthelette, P.; Blackwell, C.; Carr, T.; Clemens, J.; Donaldson, T.; Gillespie, F.; Guido, T.; Hagoplan, S.; Johnson-Wood, K.; Khan, K.; Lee, M.; Leibowitz, P.; Lieberburg, I.; Little, S.; Masilah, E.; McConlogue, L.; Montoya-Zavala, M.; Mucke, L.; Paganini, L.; Penniman, E.; Power, M.; Schenk, D.; Seubert, P.; Snyder, B.; Sorlano, F.; Tan, H.; Vitale, J.; Wadsworth, S.; Wolozin, B.; Zhao, J. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373:523-527; 1995.
15. 15. Giaccone, G.; Tagliavini, F.; Linoni, G.; Bouras, C.; Frigerio, L.; Frangione, B.; Bugiani, O. Down patients: Extracellular preamyloid deposits precede neuritic degeneration and senile plaques. Neurosci. Lett. 97:232-238; 1989.
16. 16. Giordano, T.; Pan, J. B.; Monteggia, L. M.; Holzman, T. F.; Snyder, S. W.; Krafft, G.; Ghanbari, H.; Kowall, N. W. Similarities between β Amyloid peptides 1-40 and 40-1: Effects on aggregation, toxicity in vitro, and injection in young and aged rats. Exp. Neurol. 125:175-182; 1994.
17. 17. Giovannelli, F.; Casamenti, F.; Scali, C.; Bartolini, L.; Pepeu, G. Differential effects of amyloid peptides β-(1-40) and β-(25-35) injections into the rat nucleus basalis. Neuroscience 66:781-792; 1995.
18. 18. Glenner, G. C.; Wong, C. W. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120:885-890; 1984.
19. 19. Goate, A.; Chartier-Harlin, M.C.; Mullan, M.; Brown, J.; Crawford, F.; Fidani, L.; Giuffra, L.; Haynes, A.; Irving, N.; James, L.; Man, R.; Newton, P.; Rooke, K.; Roques, P.; Talbot, C.; Williamson, R.; Rossor, M.; Owen, M.; Hardy, J. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704-707; 1991.
20. 20. Goedert, M.; Spillantini, M. G.; Jakes, R. Localization of the Alz-50 epitope in recombinant human microtubule-associated protein tau. Neurosci. Lett. 126:149-154; 1991.
21. 21. Gong, C. -X.; Singh, T. J.; Grundke-Iqbal, I.; Iqbal, K. Phosphoprotein phosphatase activities in Alzheimer disease brain. J. Neurochem. 61: 921-927; 1993.
22. 22. Hansen, L. A.; Armstrong, D. M.; Terry, R. D. An immunohistochemical quantification of fibrous astrocytes in the aging cerebral cortex. Neurobiol. Aging 8:1-6; 1987.
23. 23. Hatten, M. E.; Liem, R. K.; Shelanski, M. L.; Mason, C. A. Astroglia in CNS injury. Glia 4:233-243; 1991.
24. 24. Jamada, M.; Mehraein, P. Verteilungsmuster der senilien Veränderungen im Gehirn. Die Beteiligung des limbischen Systems bei hirnatrophischen Prozessen des Senium und bei Morbus Alzheimer. Arch. Psychiatr. Nervenkrankheiten 211:308-324; 1968.
25. 25. Kang, J.; Lemaire, H. -G.; Unterbeck, A.; Salbaum, J. M.; Masters, C. L.; Grzeschik, K. -H.; Multhaup, G.; Beyreuther, K.; Muller-Hill, B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325:733-736; 1987.
26. 26. Kidd, M. Alzheimer's disease. An electron microscopical study. Brain 87:307-320; 1964.
27. 27. Kondo, J.; Honda, T.; Mori, H.; Hamada, Y.; Miura, R.; Ogawara, M.; Ihara, Y. The carboxyl third of tau is tightly bound to paired helical filaments. Neuron 1:827-834; 1988.
28. 28. Kowall, N. W.; Beal, M. F.; Busciglio, J.; Duffy, L. K.; Yankner, B. A. An in vivo model for the neurodegenerative effects of β amyloid and protection by substance P. Proc. Natl. Acad. Sci. USA 88:7247-7251; 1991.
29. 29. Kowall, N. W.; McKee, A. C.; Yankner, B. A.; Beal, M. F. In vivo neurotoxicity of beta amyloid [β(1-40)] and the β(25-35) fragment. Neurobiol. Aging 13:537-542; 1991.
30. 30. Kowall, N. W.; McKee, A. C. The histopathology of neuronal degeneration and plasticity in Alzheimer disease. Adv. Neurol. 59:5-33; 1993.
31. 31. Ksiezak-Reding, H.; Liu, W. -K.; Hradsky, J.; Yen, S. -H. Phosphate analysis of different tau preparations from normal and Alzheimer disease brains. J. Cell Biol. 111:435a; 1990.
32. 32. Ksiezak-Reding, H.; Chien, C-H.; Lee, V. M.-Y.; Yen, S.-H. Mapping of the Alz-50 epitope in microtubule-associated proteins tau. J. Neurosci. Res. 25:412-419; 1990.
33. 33. Lai, F.; Williams, R. S. A prospective study of Alzheimer's disease in Down's syndrome. Arch. Neurol. 46:849-853; 1989.
34. 34. Lee, J. M.; Hejna, G.; Sigurdsson, E.; Singh, S.; Lorens, S. A. β-Amyloid (β/A4) 25-35 induces degeneration of median but not dorsal raphe neurons in the rat. FASEB J. 6:A1916; 1992.
35. 35. Malouf, A. T. Effect of beta amyloid peptides on neurons in hippocampal slice cultures. Neurobiol. Aging 13:543-551; 1992.
36. 36. Mann, D. M. A.; Yates, P. O.; Marcyniuk, B.; Ravindra, C. R. The topography of plaques and tangles in Down's syndrome patients of different ages. Neuropathol. Appl. Neurobiol. 12:447-457; 1986.
37. 37. Mann, D. M. A.; Tucker, C. M.; Yates, P. O. The topographic distribution of senile plaques and neurofibrillary tangles in the brains of non-demented persons of different ages. Neuropathol. Neurobiol. 13: 123-139; 1987.
38. 38. Mann, D. M. A.; Esiri, M. M. The site of the earliest lesions of Alzheimer's disease. N. Engl. J. Med. 318:789-790; 1988.
39. 39. Mann, D. M. A.; Esiri, M. M. Regional acquisition of plaques and tangles in Down's syndrome patients under 50 years of age. J. Neurol. Sci. 89:169-179; 1989.
40. 40. Mann, D. M. A. Cerebral amyloidosis, aging and Alzheimer's disease. A contribution from studies in Down's syndrome. Neurobiol. Aging 10:397-399; 1989.
41. 41. Masters, C. L.; Simms, G.; Weinman, N. A.; Multhaup, G.; McDonald, B. L.; Beyreuther, K. Amyloid plaque core protein in Alzheimer's disease and Down's syndrome. Proc. Natl. Acad. Sci. USA 82:4245-4249; 1985.
42. 2+ influx in cultured hippocampal neurons. Neuron 2:105-117; 1990.
43. 43. Mattson, M. P.; Cheng, B.; Davis, D.; Bryant, K.; Lieberburg, I.; Rydel, R. E. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12:376-389; 1992.
44. 44. Miller, D. L.; Papayannopoulos, I. A.; Styles, J.; Bobin, S. A.; Lin, Y. Y.; Biemann, K.; Iqbal, K. Peptide composition of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch. Biochem. Biophys. 301:41-52; 1993.
45. 45. Morishima-Kawashima, M.; Hasegawa, M.; Takio, K.; Suzuki, M.; Yoshida, H.; Titani, K.; Ihara, Y. Proline-directed and non-proline-directed phosphorylation of PHF-tau. J. Biol. Chem. 270:823-829; 1995.
46. 46. Murphy, G. M. Jr.; Ellis, W. G. The amygdala in Down's syndrome and familial Alzheimer's disease: Four clinicopathological case reports. Biol. Psychiatry 30:92-106; 1991.
47. 47. Nieto-Sampedro, M. Astrocytic mitogenic activity in aged normal and Alzheimer's human brain. Neurobiol. Aging 8:249-252; 1987.
48. 48. Norton, W. T.; Aquino, D. A.; Hozumi, I.; Chiu, F. -C.; Brosnan, C. F. Quantitative aspects of reactive gliosis: A review. Neurochem. Res. 17:877-885; 1992.
49. 49. Palmer, A. M.; Proctor, A. W.; Stratmann, G. C.; Bowen, D. M. Excitatory amino acid-releasing and cholinergic neurons in Alzheimer's disease. Neurosci. Lett. 66:199-204; 1986.
50. 50. Papasozomenos, S. C.; Binder, L. I. Phosphorylation determines two distinct species of tau in the central nervous system. Cell Motil. Cytoskel. 8:210-226; 1987.
51. 51. Paxinos, G.; Watson, C. The rat brain in stereotaxic coordinates. 2nd ed. San Diego, CA: Academic Press; 1986.
52. 52. Pearson, R. C. A.; Powell, T. P. S. The neuroanatomy of Alzheimer's disease. Rev. Neurosci. 2:101-122; 1989.
53. 53. Pike, C.; Walencewicz, A.; Glabe, C.; Cotman, C. In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563:311-314; 1991.
54. 54. Pike, C. J.; Burdick, D.; Walencewicz, A. J.; Glabe, C. G.; Cotman, C. W. Neurodegeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state. J. Neurosci. 13:1676-1687; 1993.
55. 55. Pike, C. J.; Cummings, B. J.; Monzavi, R.; Cotman, C. W. β-Amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease. Neurosci. 63: 517-531; 1994.
56. 56. Podlisny, M. B.; Stephenson, D. T.; Frosch, M. P.; Lieberburg, I.; Clemens, J. A.; Selkoe, D. J. Synthetic amyloid β-protein fails to produce specific neurotoxicity in monkey cerebral cortex. Neurobiol. Aging 13:561-567; 1992.
57. 57. Price, J. L.; Russcehn, F. T.; Amaral, D. G. The limbic region. II: The amygdaloid complex. In: Björklund, A.; Hökfelt, T.; Swanson, L. W., eds. Handbook of Chemical Neuroanatomy. Amsterdam: Elsevier Science Publishers; 1987:279-388.
58. 58. Roher, A. E.; Lowenson, J. D.; Clarke, S.; Wolkow, C.; Wang, R.; Cotter, R. J.; Reardon, I. M.; Zürcher-Neely, H. A.; Heinrikson, R. L.; Ball, M. J.; Greenberg, B. D. Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J. Biol. Chem. 268:3072-3083; 1993.
59. 59. Rumble, B.; Retallack, R.; Hilbich, C.; Simms, G.; Multhaup, G.; Martins, R.; Hockey, A.; Montgomery, P.; Beyreuther, K.; Masters, C. L. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N. Engl. J. Med. 320:1446-1452; 1989.
60. 60. Rush, D. K.; Aschmies, S.; Merriman, M. C. Intracerebral β-amyloid (25-35) produces tissue damage. Is it neurotoxic? Neurobiol. Aging 13:591-594; 1992.
61. 61. Rye, D. B.; Leverenz, J.; Greenberg, S. G.; Davies, P.; Saper, C. B. The distribution of Alz-50 immunoreactivity in the normal human brain. Neuroscience 56:109-127; 1993.
62. 62. Shimohama, S.; Fujimoto, S.; Taniguchi, T.; Kameyama, M.; Kimura, J. Reduction of low-molecular-weight acid phosphatase activity in Alzheimer brains. Ann. Neurol. 33:616-621; 1993.
63. 63. Sigurdsson, E. M.; Hejna, M. J.; Lee, J. M.; Lorens, S. A. β-Amyloid 25-35 and/or quinolinic acid injections into the basal forebrain of young male F344 rats: Behavioral, neurochemical and histological effects. Behav. Brain Res. 72:141-156; 1995.
64. 64. Smyth, M. D.; Kesslak, J. P.; Cummings, B. J.; Cotman, C. W. Analysis of brain injury following intrahippocampal administration of β-amyloid in streptozotocin-treated rats. Neurobiol. Aging 15:153-159; 1994.
65. 65. Takashima, A.; Noguchi, K.; Sato, K.; Hoshino, T.; Imahori, K. Tau protein kinase I is essential for amyloid β-protein-induced neurotoxicity. Proc. Natl. Acad. Sci. USA 90:7789-7793; 1993.
66. 66. Terry, R. D. The fine structure of neurofibrillary tangles in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 22:629-642; 1963.
67. 67. Uéda, K.; Masliah, E.; Saitoh, T.; Bakalis, S. L.; Scobie, H.; Kosik, K. S. Alz-50 recognizes a phosphorylated epitope of tau protein. J. Neurosci. 10:3295-3303; 1990.
68. 68. Watanabe, N.; Takio, K., Hasegawa, M.; Arai, T.; Titani, K.; Ihara, Y. Tau 2: A probe for a Ser conformation in the amino terminus of τ. J. Neurochem. 58:960-966; 1992.
69. 69. Whitson, J. S.; Selkoe, D. J.; Cotman, C. W. Amyloid β-protein enhances the survival of hippocampal neurons in vitro. Science 243: 1488-1490; 1989.
70. 70. Winkler, J.; Connor, D. J.; Frautschy, S. A.; Behl, C.; Waite, J. J.; Cole, G. M.; Thal, L. J. Lack of long-term effects after β-amyloid protein injections in rat brain. Neurobiol. Aging 15:601-607; 1994.
71. 71. Wischik, C. M.; Novak, M.; Thogersen, H. C.; Edwards, P. C.; Runswick, M. J.; Jakes, R.; Walker, J. E.; Milstein, C.; Roth, M.; Klug, A. Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc. Natl. Acad. Sci. USA 85:4506-4510; 1988.
72. 72. Wischik, C. M.; Novak, M.; Edwards, P. C.; Klug, A.; Tichelaar, W.; Crowther, R. A. Structure and characterization of the core of the paired helical filament of Alzheimer disease. Proc. Natl. Acad. Sci. USA 85:4884-4888; 1988.
73. 73. Wisniewski, K. E.; Wisniewski, H. M.; Wen, G. Y. Occurrence of neuropathologic changes and dementia of Alzheimer's disease in Down's syndrome. Ann. Neurol. 17:278-282; 1985.
74. 74. Yankner, B. A.; Dawes, L. R.; Fisher, S.; Villa-Komaroff, L.; Oster-Granite, M.; Neve, R. L. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 245:417-420; 1989.
75. 75. Yankner, B. A.; Duffy, L. K.; Kirschner, D. A. Neurotrophic and neurotoxic effects of amyloid β-protein: Reversal by tachykinin neuropeptides. Science 250:279-282; 1990.